1 / 45

CLINICAL INVESTIGATION UNIT TESTS

CLINICAL INVESTIGATION UNIT TESTS. Presented by: ALAA MONJED Endocrinology fellow. OUTLINE. Background- Provocative endocrine tests CIU tests Indications Side effects / Contraindications. Background. What can we measure? basal hormone levels stimulated or suppressed hormone levels

hao
Télécharger la présentation

CLINICAL INVESTIGATION UNIT TESTS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CLINICAL INVESTIGATION UNIT TESTS Presented by: ALAA MONJED Endocrinology fellow

  2. OUTLINE • Background- Provocative endocrine tests • CIU tests • Indications • Side effects / Contraindications

  3. Background • What can we measure? • basal hormone levels • stimulated or suppressed hormone levels • Why do we do dynamic endocrine testing? • test of secretory reserve

  4. INSUFFICIENCY/DEFICIENCY Stimulate! • OVERPRODUCTION Suppress!

  5. Clinical Investigation Unit - CIU • Liz Froats, RN • Room B5-502 http://dom.lhsc.on.ca/dom/divisions/endo/ciu.htm

  6. http://lhdomws.lhsc.on.ca/dom/divisions/endo/ciu.htm

  7. Available CIU Tests

  8. Examples

  9. EVALUATION OF GROWTH HORMONE DEFICIENCY • Screening test: low IGF-1 level • butnormal IGF-1 does not exclude it • Dynamic tests: • because basal levels of GH are usually low, which do not distinguish between normal and GH-deficient patients. • Insulin induced hypoglycemia • Most reliable stimulus to GH secretion • A subnormal increase in serumGH(<5.1 ng/mL) confirms the diagnosis of growth hormone deficiency

  10. ITT 14 units of insulin given

  11. Interpretation: • abnormal • Why? • Glucose fell to <2.2 mm • Normally GH should rise over 10

  12. 2. GHRH-Arginine test • 1mg GHRH combined with a 30-min infusion of Arginine IV to stimulate GH secretion • Possible side effects: mild flushing, metallic taste, N/V • Contraindications: severe liver or renal disease

  13. 3.Glucagon stimulation test • 1 mg Glucagon IM, followed by measurement of GH every 30 min for 3 hours • Useful when ITT is contraindicated or GHRH is not available • Side effects: nausea, vomiting and possible late hypoglycemia • Contraindications: malnourished patients • Failure of GH to rise > 3ng/ml is a positive test

  14. Evaluation Of GH Hypersecretion/Acromegaly • Screening test: high IGF-1 level • Dynamic tests: • Oral glucose tolerance test • Failure of GH suppression or paradoxical rise in GH level confirms Acromegaly • Also, seen in starvation, anorexia nervosa, and protein-calorie malnutrition • Side effects: nausea • If a radioimmunoassay method= GH level > 1mcg/L • If one of the newer, highly sensitive immunoradiometricGH assays is used= GH level >0.3 mcg/L

  15. Interpretation?

  16. Evaluation Of LH/FSH Deficiency • Measurement of gonadal steroids (estradiol, testosterone). • Measurement of LH/FSH. • Primary gonadal failure • Low gonadal steroids, High LH/FSH • Hypogonadotrophichypogonadism • Low gonadal steroids, LH,FSH • GnRH test • Assess LH/FSH secretory reserve by stimulating their secretion • Uncommonly performed

  17. Evaluation Of TSH(Secondary Hypothyroidism) • Measurement of TSH • Measurement of free T4/free T3 • If high TSH, low T4 ……. • If low/normal TSH, low T4 ……. 3. TRH stimulation test • is rarely done now because of the accurate methods of determining TSH and freeT4

  18. EVALUATION OF HYPOPITUITARISM • Components: • Insulin Tolerance Test • GH deficiency, adrenal insufficiency • GnRH stimulation test • hypogonadotropichypogonadism • TRH stimulation test • central hypothyroidism, hypoprolactinemia

  19. 1984. J Neurosurg 61(3):586-590

  20. ACTH and Cortisol Secretion Kronenberg HM et al.Williams Textbook of Endocrinology. 11th edition. 2008 Saunders Elsevier.

  21. ACTH and Cortisol Secretion • pulsatile secretion • circadian rhythm • highest in a.m. 24:00 08:00 12:00 20:00 Kronenberg HM et al.Williams Textbook of Endocrinology. 11th edition. 2008 Saunders Elsevier.

  22. Pituitary-Adrenal ReserveDynamic Tests • Used to evaluate the ability of the HPA axis to respond to stress • ACTH stimulation test: directly stimulates adrenal secretion • Metyrapone test: inhibits cortisol synthesis and stimulates pituitary ACTH secretion • Insulin-induced hypoglycemia: stimulates ACTH secretion by increasing CRH • CRH test: stimulates directly the pituitary corticotrophs to release ACTH

  23. Adrenal Insufficiency Diagnosis Steps: • To rule out adrenal insufficiency - fasting 08:00 am cortisol • if 08:00 am cortisol >524 nmol/L, adrenal insufficiency excluded • if 08:00 am cortisol <83 nmol/L, adrenal insufficiency confirmed • if 08:00 am cortisol between these values, is borderline – need further testing reviewed in Oelkers W. N Engl J Med 1996; 335(16):1206-1212

  24. Adrenal Insufficiency Diagnosis Steps: • If suspect primary adrenal insufficiency, do both 08:00 am cortisol and ACTH • low cortisol and high ACTH - primary • if cortisol normal – rules out primary, but does not exclude mild secondary adrenal insufficiency • in primary adrenal insufficiency – ACTH usually >22pmol/L • low cortisol and low/normal ACTH – secondary/tertiary

  25. Adrenal Insufficiency Diagnosis • Dynamic Tests: • To confirm adrenal insufficiency: • High dose ACTH stimulation test • Fasting is not required • 250 mg cosyntropin (Cortrosyn) IV/IM • Cortisol/ACTH at -15, 0, 30, 60 min • If peak cortisol >500 nmol/L (preferably >550 nmol/L), rules out primary adrenal insufficiency Oelkers W. N Engl J Med 1996; 335(16):1206-1212

  26. A normal response to ACTH stimulation test: • Excludes primary AI • Excludes overt secondary AI with adrenal atrophy • Dose not rule out partial ACTH deficiency • pts with sufficient basal ACTH secretion to prevent adrenocortical atrophy • Or pts with recently developed secondary AI who have not yet undergone adrenal atrophy • In such patients, other pituitary-adrenal reserve dynamic testing may be indicated

  27. Adrenal Insufficiency Diagnosis • Low dose short ACTH stimulation test • must be undertaken in the morning • 1 mg cosyntropin (Cortrosyn) IV • Cortisol/ACTH at -15, 0, 30, 60 min • Normal peak cortisol >500 nmol/L • 2 meta-analyses comparing low vs. high dose tests had conflicting results: • Dorin et al. 2003 – no difference in sensitivity or specificity • Kazlauskaite et al. 2008 – low dose test had higher sensitivity Oelkers W. N Engl J Med 1996; 335(16):1206-1212

  28. Adrenal Insufficiency Diagnosis • Insulin-induced hypoglycemia test: • It measures the integrity of the HPA axis and its ability to respond to stress • Normal plasma cortisol response: an increment >220nmol/l and a peak level >550 nmol/l • Normal ACTH response > 22pmol/l • A normal response exclude AI and decreased pituitary reserve i.e. no need to cortisol therapy during illness or stress • Contraindicated in: Elderly, CVD, CVA and seizure disorders

  29. Adrenal Insufficiency Diagnosis • To distinguish secondary vs. tertiary adrenal insufficiency: CRH stimulation test (if you can get CRH!) • 100 mg CRH IV • ACTH, cortisol at -15, 0, 30, 60, 90 min • low/absent ACTH = pituitary adrenal insufficiency (secondary) • high ACTH = hypothalamic adrenal insufficiency (tertiary) (values not as well standardized as for ITT) Oelkers W. N Engl J Med 1996; 335(16):1206-1212

  30. Posterior Pituitary

  31. Diabetes Insipidus • Central • Antidiuretic hormone deficiency • Responds to Desmopressin • Diagnosis: • Water Restriction Test

  32. Water Restriction Test

  33. Water Deprivation Test

  34. Interpretation: abnormal, consistent with central DI • Why? • Serum osmolality rose but urine osmolality remained relatively dilute still; similarly serum Na rose • [At ** time DDAVP was given and serum/urine/Na responded appropriately]

  35. REFRENCES • Kronenberg HM et al.Williams Textbook of Endocrinology. 11th edition. 2008 Saunders Elsevier. • Gardner DG & Shoback D (eds) Greenspan’s Basic & Clinical Endocrinology, 9th Edition.2011 McGraw-Hill. • www.uptodate.com • http://dom.lhsc.on.ca/dom/divisions/endo/ciu.htm

  36. THANK YOU

More Related